Comparing the efficacy and safety of nafamostat mesylate versus citrate for anticoagulation in continuous renal replacement therapy: a systematic review and meta-analysis - Top-Institutions - MDSpire

Comparing the efficacy and safety of nafamostat mesylate versus citrate for anticoagulation in continuous renal replacement therapy: a systematic review and meta-analysis

  • By

  • Zhao Hua Zou

  • Ji Quan Zhang

  • Pei Jun Xiang

  • Xing Chen

  • Wei Qing

  • July 6, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    The University of Tokyo Hospital
    The University of Tokyo Hospital

    Tokyo, Tokyo

    Key Differentiators

    • Nephrology
    • Intensive Care
  • #2

    First Affiliated Hospital of Sun Yat‑sen University
    First Affiliated Hospital of Sun Yat‑sen University

    Guangzhou, Guangdong

    Key Differentiators

    • Nephrology
    • Critical Care Medicine
  • #3

    Shanghai Tenth People’s Hospital, Tongji University School of Medicine
    Shanghai Tenth People’s Hospital, Tongji University School of Medicine

    Shanghai, Shanghai

    Key Differentiators

    • Nephrology
    • Intensive Care
  • #4

    University Hospital Zurich
    University Hospital Zurich

    Zurich, Zurich

    Key Differentiators

    • Nephrology
    • Intensive Care
  • #5

    Lyon Medical and Surgical ICUs
    Lyon Medical and Surgical ICUs

    Lyon, Auvergne-Rhône-Alpes

    Key Differentiators

    • Nephrology
    • Intensive Care

Original Source(s)

Related Content